This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Lithium chloride is an injection indicated for cardiac output measurement.
- Generic Name
- Lithium chloride
- DrugBank Accession Number
- DB16607
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Lithium chloride (DB16607)
- Weight
- Average: 42.39
Monoisotopic: 41.9848561 - Chemical Formula
- ClLi
- Synonyms
- Lithium muriaticum
- External IDs
- 231-212-3
- NSC-327172
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareBexagliflozin The serum concentration of Lithium chloride can be decreased when it is combined with Bexagliflozin. Cisatracurium Lithium chloride may increase the neuromuscular blocking activities of Cisatracurium. Dapagliflozin The serum concentration of Lithium chloride can be decreased when it is combined with Dapagliflozin. Ertugliflozin The excretion of Lithium chloride can be increased when combined with Ertugliflozin. Insulin aspart The therapeutic efficacy of Insulin aspart can be increased when used in combination with Lithium chloride. - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- G4962QA067
- CAS number
- 7447-41-8
- InChI Key
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M
- InChI
- InChI=1S/ClH.Li/h1H;/q;+1/p-1
- IUPAC Name
- chlorolithium
- SMILES
- [Li]Cl
References
- General References
- BASG: Lithiumchlorid LiDCO 0,15 mmol/ml Injektionslösung (Lithium Chloride) Intravenous Injection [Link]
- External Links
- ChemSpider
- 22449
- BindingDB
- 50494542
- 1311533
- ChEBI
- 48607
- ChEMBL
- CHEMBL69710
- Wikipedia
- Lithium_chloride
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Parenteral 0.15 mmol/ml - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 0.63 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 6.14 m3·mol-1 Chemaxon Polarizability 4.34 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 112.06731 predictedDeepCCS 1.0 (2019) [M+H]+ 113.94416 predictedDeepCCS 1.0 (2019) [M+Na]+ 121.83831 predictedDeepCCS 1.0 (2019)
Drug created at February 16, 2021 18:56 / Updated at May 05, 2021 20:33